Jane Street’s Biomerica BMRA Stock Holding History

Jane Street’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,498	Closed	-$12.3K	–	9595
2024 Q2	$12.3K	Buy	+3,498	New	+$17.8K	﹤0.01%	9085
2022 Q2	–	Sell	-1,602	Closed	-$57K	–	9679
2022 Q1	$57K	Buy	+1,602	New	+$53.3K	﹤0.01%	9648

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street's BMRA Position: Q3 2024 in Review

Jane Street sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 3,498 shares — an estimated $12.3K sold.

Jane Street first reported a position in BMRA in Q1 2022 and held it in 2 quarters. The position peaked at $57K in Q1 2022. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

Jane Street reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
Jane Street sold 3,498 Biomerica shares in Q3 2024, an estimated $12.3K.
Jane Street first reported a position in Biomerica in Q1 2022 and held it in 2 quarters.
Jane Street's Biomerica position peaked at $57K in Q1 2022.
25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.